Market Place
Sourcing Support
Newleos Doses First Patient in NTX-2001 Alcohol Use Trial
29 Apr 2026 //
BUSINESSWIRE
Newleos Doses First Participant in UK Phase 1b NTX-1955 GAD Trial
01 Apr 2026 //
PHARMIWEB
Newleos Doses First Patient in SOAR Phase 2 Anxiety Study
06 Jan 2026 //
BUSINESSWIRE
Newleos Therapeutics Names Timothy Noyes President, CEO
21 Oct 2025 //
PHARMIWEB
Newleos Pharma CEO Donabedian Honored By Goldman Sachs At 2025
15 Oct 2025 //
PHARMIWEB
Newleos Therapeutics Advances Neuropsychiatric Pipeline Progress
30 Sep 2025 //
BUSINESSWIRE
Newleos Posts 2025 Psychiatry Congress Data in Poster Session
09 Sep 2025 //
BUSINESSWIRE
Newleos Adds Stephen Brannan to Board, Updates on NTX-1955
23 Jul 2025 //
BUSINESSWIRE
Newleos Forms Clinical Advisory Board for Neuropsychiatry Program
29 Apr 2025 //
BUSINESSWIRE
Newleos Therapeutics Expands Leadership Team for Growth
08 Apr 2025 //
BUSINESSWIRE
Newleos Launches With $93.5M Series A To Neuropsychiatric Medicines
13 Feb 2025 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.